You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for JAZZ PHARMACEUTICALS IRELAND LIMITED v. LUPIN LTD. (D.N.J. 2023)

✉ Email this page to a colleague

« Back to Dashboard

JAZZ PHARMACEUTICALS IRELAND LIMITED v. LUPIN LTD. (D.N.J. 2023)

Docket	⤷ Sign Up	Date Filed	2023-01-20
Court	District Court, D. New Jersey	Date Terminated
Cause	35:271 Patent Infringement	Assigned To
Jury Demand	None	Referred To
Parties	LUPIN INC.
Patents	10,213,400; 6,322,819; 6,384,020; 6,780,889; 7,262,219; 7,668,730; 7,765,106; 7,765,107; 7,851,506; 7,895,059; 8,101,209; 8,202,537; 8,263,125; 8,263,650; 8,324,275; 8,457,988; 8,589,182; 8,731,963; 8,772,306; 8,859,619; 8,952,062; 9,050,302; 9,486,426; 9,539,330
Attorneys	CHARLES MICHAEL LIZZA
Firms	Saul Ewing LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in JAZZ PHARMACEUTICALS IRELAND LIMITED v. LUPIN LTD.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Biologic Drugs cited in JAZZ PHARMACEUTICALS IRELAND LIMITED v. LUPIN LTD.

The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for JAZZ PHARMACEUTICALS IRELAND LIMITED v. LUPIN LTD. (D.N.J. 2023)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2023-01-19	1	Complaint	the ’302 patent”); 9,486,426 (“the ’426 patent”); 8,772,306 (“the ’306 patent”); 10,213,400 (“the ’400…0269641 A1 9/2019 Mégret et al . 10,213,400 B2 2/2019 Eller …400 patent”); 10,864,181 (“the ’181 patent”); 11,253,494 (“the ’494 patent”); and the ’373 patent are …United States Patent Nos. 11,426,373 (“the ’373 patent”) and 11,554,102 (“the ’102 patent”) (together,… claims of U.S. Patent Nos. 8,591,922 (“the ’922 patent”); 8,901,173 (“the ’173 patent”); 9,132,107 (	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.